Enalapril: new possibilities

QR Code

Enalapril: new possibilities

The review presents the modern evidence on new properties of enalapril, which widens our perception of therapeutic effects of this medication.

Saved in:

Bibliographic Details
Main Author:	E. O. Taratukhin
Format:	Article
Language:	Russian
Published:	«SILICEA-POLIGRAF» LLC 2012-10-01
Series:	Кардиоваскулярная терапия и профилактика
Subjects:	arterial hypertension heart failure angiotensin-converting enzyme
Online Access:	https://cardiovascular.elpub.ru/jour/article/view/1922
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

ENALAPRIL MALEATE IN TREATMENT OF ARTERIAL HYPERTENSION IN PATIENTS WITH DIABETES MELLITUS
by: L. I. Katelnitskaya, et al.
Published: (2002-10-01)

Perindopril and hydrochlorthiazide effects on endothelium-dependent vasodilatation and angiotensin-converting enzyme activity in patients with mild to moderate arterial hypertension
by: T. V. Aparina, et al.
Published: (2005-06-01)

Effect of Medical Therapy on Reducing the Risk of Pacing‐Induced Cardiomyopathy
by: Mahdi S. Agha, et al.
Published: (2025-07-01)

Angiotensin II and COVID-19. Secrets of interactions
by: A. O. Konradi, et al.
Published: (2020-05-01)

Angiotensin Converting Enzyme Inhibitors: Interaction Issues in Patients with Glaucoma and Arterial Hypertension. Review
by: S. I. Makogon, et al.
Published: (2023-12-01)

Planning and Evaluation of Bioequivalence Studies of Enalapril Products
by: D. P. Romodanovsk, et al.
Published: (2018-12-01)

Effect of insertion/deletion polymorphism of angiotensin-converting enzyme gene on efficacy of antihypertensive therapy with angiotensin II receptor blockers
by: E. V. Rebrova, et al.
Published: (2024-01-01)

IMPACT OF PREOPERATIVE ENALAPRIL USE ON THE COURSE OF ANESTHESIA DURING EXTENSIVE ABDOMINAL SURGERY IN ELDERLY PATIENTS
by: N. V. Trembach, et al.
Published: (2017-11-01)

RENIN-ANGIOTENSIN SYSTEM IN REGULATION OF HEMATOPOIESIS
by: M. L. Kanaeva, et al.
Published: (2018-02-01)

Dynamics of the main parameters of structure-functional condition of the left ventricle myocardium in usage of combination antihypertension therapy for postmenopausal women with different obesity patterns
by: V. V. Skibitsky, et al.
Published: (2016-04-01)

Prospects of using genetic testing to increase the effectiveness of antihypertensive therapy
by: N. V. Drobotya, et al.
Published: (2020-06-01)

NEW POSSIBILITIES OF STATIN THERAPY IN ARTERIAL HYPERTENSION
by: E. M. Khurs, et al.
Published: (2016-01-01)

Debatable points of using angiotensin-converting enzyme inhibitors and angiotensin receptor antagonists in patients with COVID-19
by: O. M. Drapkina, et al.
Published: (2020-07-01)

The effects of angiotensin-converting enzyme inhibitors in heart recipients: a single center experience
by: А. О. Shevchenko, et al.
Published: (2019-01-01)

Controlled arterial hypertension and adverse event free survival rate in heart recipients
by: A. О. Shevchenko, et al.
Published: (2018-08-01)

Pharmacogenetics in treatment of anthracycline-induced cardiotoxicity in women without prior cardiovascular diseases
by: E. V. Grakova, et al.
Published: (2023-01-01)

INACTIVATION OF RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM. WHICH CLASS OF ANTIHYPERTENSIVE MEDICINE PRODUCTS TO PREFER?
by: S. V. Stolov
Published: (2020-12-01)

Treatment of Patients with COVID-19 and Concomitant Cardiovascular Diseases: Do not Forget About the Principles of Evidence-based Medicine
by: S. Yu. Martsevich
Published: (2020-05-01)

Metabolic Products and Biological Roles of Lactic Acid Bacteria in Fermented Products of Dairy: A Review
by: Raghad Saad Al Musa, et al.
Published: (2025-06-01)

COMBINATION OF ANGIOTENSIN-CONVERTING ENZYME INHIBITORS AND CALCIUM CHANNEL BLOCKERS IN HYPERTENSIVE PATIENTS WITH HEART FAILURE AND PRESERVED SYSTOLIC FUNCTION: IS THERE A PLACE FOR AN INFORMED CHOICE?
by: I. V. Zhirov, et al.
Published: (2013-12-01)

AN ANGIOTENSIN-CONVERTING ENZYME INHIBITOR AND CALCIUM ANTAGONIST COMBINATION IN PHARMACOTHERAPY OF ARTERIAL HYPERTENSION
by: L. L. Kirichenko, et al.
Published: (2014-02-01)

Angiotensins and rheumatoid arthritis
by: N. M. Savushkina, et al.
Published: (2019-01-01)

Experimental evidence for the topical use of angiotensin-converting enzyme inhibitors in eye drops for eye ischemia treatment
by: N. B. Chesnokova, et al.
Published: (2022-09-01)

COMPARISON OF EFFECTIVENESS OF COMBINATION ANTIHYPERTENSION THERAPY IN WOMEN WITH ABDOMINAL OR GLUTEO-FEMORAL OBESITY
by: V. V. Skibitsky, et al.
Published: (2016-10-01)

RAMIPRIL IN THERAPY OF PATIENTS AFTER MYOCARDIAL INFARCTION
by: I. V. Szirov, et al.
Published: (2015-12-01)

Optimisation of arterial hypertension therapy in patients with metabolic disorders: aspect of fixed combination lipophilic of perindopril and amlodipine
by: Andrey A. Svistunov, et al.
Published: (2025-06-01)

The role of the classical renin–angiotensin system and angiotensin-converting enzyme 2/Ang(1–7)/Mas axis in pulmonary fibrosis
by: Changhui Lang, et al.
Published: (2025-07-01)

Myocardial and Renal Renin–Angiotensin System Enzyme Activity in Dogs
by: Emma C. Weitzhandler, et al.
Published: (2025-07-01)

TO THE 110-TH ANNIVERSARY OF RENIN FINDING. FIGHT OF TITANS: ANGIOTENSIN CONVERTING ENZYME INHIBITORS AND SARTANS
by: L. N. Malay, et al.
Published: (2016-01-01)

ANGIOTENSIN CONVERTING ENZYME INHIBITORS AND ANGIOTENSIN RECEPTOR BLOCKERS: IS THERE A REASON TO CONSIDER AN EQUIVALENCE OF TWO DRUG CLASSES FROM THE EVIDENCE BASED MEDICINE STANDPOINT
by: S. Yu. Martsevich
Published: (2015-09-01)

БЕЗОПАСНОСТЬ ИНГИБИТОРОВ АНГИОТЕНЗИНПРЕВРАЩАЮЩЕГО ФЕРМЕНТА В РАННИЕ СРОКИ БЕРЕМЕННОСТИ
by: Ф. И. Белялов
Published: (2015-02-01)

Experience of using a fixed-dose combination of perindopril and amlodipine in the clinical practice settings: a real-world opportunity to increase antihypertensive therapy effectiveness
by: O. D. Ostroumova, et al.
Published: (2013-10-01)

Emergency care in a sudden individually significant blood pressure increase without clinically overt target organ damage: rationale for captopril use. Expert Council opinion
by: S. N. Tereshchenko, et al.
Published: (2020-03-01)

Variation of Concentrations of Angiotensin II, AngiotensinConverting Enzyme and Matrix Metalloprotease-9 in Tears and Serum of Patients with Diabetic Retinopathy
by: V. V. Neroev, et al.
Published: (2020-12-01)

Actual issues of the pathogenesis of COVID-19 and possible measures for the prevention of severe forms of the disease
by: Kh. G. Omarova, et al.
Published: (2021-06-01)

Hyperkalemia Associated with Angiotensin Converting Enzyme Inhibitor or Angiotensin Receptor Blockers in Chronic Kidney Disease
by: Yudi Her Oktaviono, et al.
Published: (2020-04-01)

Hyperkalemia Associated with Angiotensin Converting Enzyme Inhibitor or Angiotensin Receptor Blockers in Chronic Kidney Disease
by: Yudi Her Oktaviono, et al.
Published: (2020-04-01)

PATIENTS WITH COMBINATION OF CHRONIC HEART FAILURE, HYPERTENSION AND HISTORY OF MYOCARDIAL INFARCTION: CLINICAL AND ANAMNESTIC CHARACTERISTICS, ADMINISTRATION OF ACE INHIBITORS, ANGIOTENSIN RECEPTOR BLOCKERS, -BLOCKERS AND ADHERENCE TO THE DRUG THERAPY (DATA OF OUTPATIENT REGISTRY RECVASA)
by: M. M. Loukianov, et al.
Published: (2017-05-01)

Acquisition of renin-angiotensin-aldosterone system inhibitors for the treatment of cardiovascular diseases in regions of the Far Eastern Federal District
by: M. S. Soboleva, et al.
Published: (2020-04-01)

VESSEL WALL STIFFNESS IN ARTERIAL HYPERTENSION AND OPPORTUNITIES FOR ITS MODULATION
by: L. L. Kirichenko, et al.
Published: (2016-12-01)